Live feed07:00:22·110dINSIDERFilingvia QuantisnowChief Business Officer Aromando Andrew bought $25,418 worth of shares (29,600 units at $0.86), increasing direct ownership by 116% to 55,100 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.ONCY· Oncolytics Biotech Inc.Health CareOriginal source
